We're All One Crisis Away from Taking Unlicensed Research Peptides

1. takes unlicensed peptides, because the insurance declined to pay for what the doctor prescribed.

2. «“people generally don't try to quantify tail risks.” Among the people I talked to, this is true»

That’s a pretty bad outlook.